Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Living With Dementia

dementiaantipsychotic drugs1 - alzheimer's disease symptoms1 - delusional misidentification1 - induced pluripotent stem cells1 - development of parkinson's1 - impaired balance and coordination1 - phosphorylated alpha-synuclein1 - brain cell damage2 - cortical neurons1 - alzheimer2 - insomnia2 - korsakoff syndrome3 - neurodegenerative movement disorder1 - white matter hyperintensities1 - symptomatic memory loss1 - hypertension3 - memory retrieval1 - memory skills1 - stroke risk factors1 - alzheimer’s and dementia1 - neuropsychological tests1 - personal care1 - csf1 - misplacing items1 - phosphodiester1 - senile atrophy and aphasia1 - healthy diet1 - alzheimer's disease risk3 - drug addiction1 - functional activation studies1 -